Translating scientific discoveries during pandemics: ensuring equity for people affected by COVID-19 and tuberculosis

Jessica Carter, Jon S. Friedland, Daniela E. Kirwan, Ruvandhi R. Nathavitharana

Source: ERJ Open Res, 6 (4) 00562-2020; 10.1183/23120541.00562-2020
Journal Issue: October
Disease area: Respiratory infections

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Jessica Carter, Jon S. Friedland, Daniela E. Kirwan, Ruvandhi R. Nathavitharana. Translating scientific discoveries during pandemics: ensuring equity for people affected by COVID-19 and tuberculosis. ERJ Open Res, 6 (4) 00562-2020; 10.1183/23120541.00562-2020

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Tuberculosis prevention must integrate technological and basic care innovation
Source: Eur Respir J 2016; 48: 1531-1532
Year: 2016


Evidence-based, agreed-upon health priorities to remedy the tuberculosis patient's economic disaster
Source: Eur Respir J 2014; 43: 1563-1566
Year: 2014


Closing the gap in surveillance of tuberculosis and HIV co-infection: a European perspective on the need for clinician–public health alliances
Source: Eur Respir J, 50 (5) 1701758; 10.1183/13993003.01758-2017
Year: 2017



Advancing preparedness for clinical research during infectious disease epidemics
Source: ERJ Open Res, 5 (2) 00227-2018; 10.1183/23120541.00227-2018
Year: 2019



Crowdfunding for respiratory research: a new frontier for patient and public engagement?
Source: Eur Respir J, 50 (4) 1701333; 10.1183/13993003.01333-2017
Year: 2017



Asthma research in Europe: a transformative agenda for innovation and competitiveness
Source: Eur Respir J, 49 (5) 1602294; 10.1183/13993003.02294-2016
Year: 2017



How to optimise patient and public involvement in your research: Doing science
Source: Breathe 2015; 11:223-227
Year: 2015


Ebola: challenges for public health – what have we learnt?
Source: International Congress 2015 – PG11 Emerging infectious diseases and pandemic planning
Year: 2015



Using a rapid prioritisation process to identify health research priorities in LMICs
Source: International Congress 2018 – Primary care management of COPD
Year: 2018

Role of research in preparedness and response to emerging disease threats in Europe
Source: ERS Course 2017 - Acute respiratory pandemics: how to plan for and manage
Year: 2017

Towards the elimination of tuberculosis: challenges ahead from a European perspective
Source: Annual Congress 2012 - Joint session with WHO and ECDC "Towards elimination of tuberculosis"
Year: 2012

A global strategy for tuberculosis research and innovation
Source: Eur Respir J, 56 (5) 2003539; 10.1183/13993003.03539-2020
Year: 2020



Good news about a bad subject: scientific evidence to help defeat multidrug/extensively drug-resistant tuberculosis
Source: Eur Respir J 2014; 44: 5-7
Year: 2014


Assessing the worldwide epidemiology of sarcoidosis: challenges and future directions
Source: Eur Respir J 2016; 48: 1545-1548
Year: 2016


Digital health to end tuberculosis in the Sustainable Development Goals era: achievements, evidence and future perspectives
Source: Eur Respir J, 50 (5) 1701632; 10.1183/13993003.01632-2017
Year: 2017



From patients to research laboratories and back: overview of the major scientific achievements and their impact in TB diagnosis, clinical management and control
Source: Annual Congress 2013 –The best of TB PANNET
Year: 2013


Living with the challenges of treating tuberculosis: The patient and healthcare professional perspective
Source: Breathe 2015; 11:71-72
Year: 2015